+
Open data
-
Basic information
Entry | ![]() | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Title | Structure of human cytoplasmic dynein-1 bound to one Lis1 | |||||||||
![]() | ||||||||||
![]() |
| |||||||||
![]() | ![]() ![]() | |||||||||
Function / homology | ![]() corpus callosum morphogenesis / establishment of planar polarity of embryonic epithelium / microtubule cytoskeleton organization involved in establishment of planar polarity / ameboidal-type cell migration / interneuron migration / ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Similarity search - Function | |||||||||
Biological species | ![]() ![]() | |||||||||
Method | ![]() ![]() | |||||||||
![]() | Reimer JM / DeSantis M / Reck-Peterson SL / Leschziner AE | |||||||||
Funding support | ![]()
| |||||||||
![]() | ![]() Title: Structures of human dynein in complex with the lissencephaly 1 protein, LIS1. Authors: Janice M Reimer / Morgan E DeSantis / Samara L Reck-Peterson / Andres E Leschziner / ![]() Abstract: The lissencephaly 1 protein, LIS1, is mutated in type-1 lissencephaly and is a key regulator of cytoplasmic dynein-1. At a molecular level, current models propose that LIS1 activates dynein by ...The lissencephaly 1 protein, LIS1, is mutated in type-1 lissencephaly and is a key regulator of cytoplasmic dynein-1. At a molecular level, current models propose that LIS1 activates dynein by relieving its autoinhibited form. Previously we reported a 3.1 Å structure of yeast dynein bound to Pac1, the yeast homologue of LIS1, which revealed the details of their interactions (Gillies et al., 2022). Based on this structure, we made mutations that disrupted these interactions and showed that they were required for dynein's function in vivo in yeast. We also used our yeast dynein-Pac1 structure to design mutations in human dynein to probe the role of LIS1 in promoting the assembly of active dynein complexes. These mutations had relatively mild effects on dynein activation, suggesting that there may be differences in how dynein and Pac1/LIS1 interact between yeast and humans. Here, we report cryo-EM structures of human dynein-LIS1 complexes. Our new structures reveal the differences between the yeast and human systems, provide a blueprint to disrupt the human dynein-LIS1 interactions more accurately, and map type-1 lissencephaly disease mutations, as well as mutations in dynein linked to malformations of cortical development/intellectual disability, in the context of the dynein-LIS1 complex. #1: ![]() Title: Structural basis for cytoplasmic dynein-1 regulation by Lis1. Authors: Gillies JP / Reimer JM / Karasmanis EP / Lahiri I / Htet ZM / Leschziner AE / Reck-Peterson SL | |||||||||
History |
|
-
Structure visualization
Supplemental images |
---|
-
Downloads & links
-EMDB archive
Map data | ![]() | 157.3 MB | ![]() | |
---|---|---|---|---|
Header (meta data) | ![]() ![]() | 19.9 KB 19.9 KB | Display Display | ![]() |
FSC (resolution estimation) | ![]() | 11.6 KB | Display | ![]() |
Images | ![]() | 45.5 KB | ||
Filedesc metadata | ![]() | 7.9 KB | ||
Others | ![]() ![]() | 154.4 MB 154.4 MB | ||
Archive directory | ![]() ![]() | HTTPS FTP |
-Related structure data
Related structure data | ![]() 8dyvMC ![]() 8dyuC C: citing same article ( M: atomic model generated by this map |
---|---|
Similar structure data | Similarity search - Function & homology ![]() |
-
Links
EMDB pages | ![]() ![]() |
---|---|
Related items in Molecule of the Month |
-
Map
File | ![]() | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Voxel size | X=Y=Z: 1.16 Å | ||||||||||||||||||||
Density |
| ||||||||||||||||||||
Symmetry | Space group: 1 | ||||||||||||||||||||
Details | EMDB XML:
|
-Supplemental data
-Half map: #2
File | emd_27783_half_map_1.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Projections & Slices |
| ||||||||||||
Density Histograms |
-Half map: #1
File | emd_27783_half_map_2.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Projections & Slices |
| ||||||||||||
Density Histograms |
-
Sample components
-Entire : Human cytoplasmic dynein-1 bound to one Lis1
Entire | Name: Human cytoplasmic dynein-1 bound to one Lis1 |
---|---|
Components |
|
-Supramolecule #1: Human cytoplasmic dynein-1 bound to one Lis1
Supramolecule | Name: Human cytoplasmic dynein-1 bound to one Lis1 / type: complex / ID: 1 / Parent: 0 / Macromolecule list: #1-#2 |
---|---|
Source (natural) | Organism: ![]() ![]() |
-Macromolecule #1: Cytoplasmic dynein 1 heavy chain 1
Macromolecule | Name: Cytoplasmic dynein 1 heavy chain 1 / type: protein_or_peptide / ID: 1 / Number of copies: 1 / Enantiomer: LEVO |
---|---|
Source (natural) | Organism: ![]() ![]() |
Molecular weight | Theoretical: 380.953594 KDa |
Recombinant expression | Organism: ![]() ![]() ![]() |
Sequence | String: GQVALEELQD LKGVWSELSK VWEQIDQMKE QPWVSVQPRK LRQNLDALLN QLKSFPARLR QYASYEFVQR LLKGYMKINM LVIELKSEA LKDRHWKQLM KRLHVNWVVS ELTLGQIWDV DLQKNEAIVK DVLLVAQGEM ALEEFLKQIR EVWNTYELDL V NYQNKCRL ...String: GQVALEELQD LKGVWSELSK VWEQIDQMKE QPWVSVQPRK LRQNLDALLN QLKSFPARLR QYASYEFVQR LLKGYMKINM LVIELKSEA LKDRHWKQLM KRLHVNWVVS ELTLGQIWDV DLQKNEAIVK DVLLVAQGEM ALEEFLKQIR EVWNTYELDL V NYQNKCRL IRGWDDLFNK VKEHINSVSA MKLSPYYKVF EEDALSWEDK LNRIMALFDV WIDVQRRWVY LEGIFTGSAD IK HLLPVET QRFQSISTEF LALMKKVSKS PLVMDVLNIQ GVQRSLERLA DLLGKIQKAL GEYLERERSS FPRFYFVGDE DLL EIIGNS KNVAKLQKHF KKMFAGVSSI ILNEDNSVVL GISSREGEEV MFKTPVSITE HPKINEWLTL VEKEMRVTLA KLLA ESVTE VEIFGKATSI DPNTYITWID KYQAQLVVLS AQIAWSENVE TALSSMGGGG DAAPLHSVLS NVEVTLNVLA DSVLM EQPP LRRRKLEHLI TELVHQRDVT RSLIKSKIDN AKSFEWLSQM RFYFDPKQTD VLQQLSIQMA NAKFNYGFEY LGVQDK LVQ TPLTDRCYLT MTQALEARLG GSPFGPAGTG KTESVKALGH QLGRFVLVFN CDETFDFQAM GRIFVGLCQV GAWGCFD EF NRLEERMLSA VSQQVQCIQE ALREHSNPNY DKTSAPITCE LLNKQVKVSP DMAIFITMNP GYAGRSNLPD NLKKLFRS L AMTKPDRQLI AQVMLYSQGF RTAEVLANKI VPFFKLCDEQ LSSQSHYDFG LRALKSVLVS AGNVKRERIQ KIKREKEER GEAVDEGEIA ENLPEQEILI QSVCETMVPK LVAEDIPLLF SLLSDVFPGV QYHRGEMTAL REELKKVCQE MYLTYGDGEE VGGMWVEKV LQLYQITQIN HGLMMVGPSG SGKSMAWRVL LKALERLEGV EGVAHIIDPK AISKDHLYGT LDPNTREWTD G LFTHVLRK IIDSVRGELQ KRQWIVFDGD VDPEWVENLN SVLDDNKLLT LPNGERLSLP PNVRIMFEVQ DLKYATLATV SR CGMVWFS EDVLSTDMIF NNFLARLRSI PLDEGEDEAQ RRRKGKEDEG EEAASPMLQI QRDAATIMQP YFTSNGLVTK ALE HAFQLE HIMDLTRLRC LGSLFSMLHQ ACRNVAQYNA NHPDFPMQIE QLERYIQRYL VYAILWSLSG DSRLKMRAEL GEYI RRITT VPLPTAPNIP IIDYEVSISG EWSPWQAKVP QIEVETHKVA APDVVVPTLD TVRHEALLYT WLAEHKPLVL CGPPG SGKT MTLFSALRAL PDMEVVGLNF SSATTPELLL KTFDHYCEYR RTPNGVVLAP VQLGKWLVLF CDEINLPDMD KYGTQR VIS FIRQMVEHGG FYRTSDQTWV KLERIQFVGA CNPPTDPGRK PLSHRFLRHV PVVYVDYPGP ASLTQIYGTF NRAMLRL IP SLRTYAEPLT AAMVEFYTMS QERFTQDTQP HYIYSPREMT RWVRGIFEAL RPLETLPVEG LIRIWAHEAL RLFQDRLV E DEERRWTDEN IDTVALKHFP NIDREKAMSR PILYSNWLSK DYIPVDQEEL RDYVKARLKV FYEEELDVPL VLFNEVLDH VLRIDRIFRQ PQGHLLLIGV SGAGKTTLSR FVAWMNGLSV YQIKVHRKYT GEDFDEDLRT VLRRSGCKNE KIAFIMDESN VLDSGFLER MNTLLANGEV PGLFEGDEYA TLMTQCKEGA QKEGLMLDSH EELYKWFTSQ VIRNLHVVFT MNPSSEGLKD R AATSPALF NRCVLNWFGD WSTEALYQVG KEFTSKMDLE KPNYIVPDYM PVVYDKLPQP PSHREAIVNS CVFVHQTLHQ AN ARLAKRG GRTMAITPRH YLDFINHYAN LFHEKRSELE EQQMHLNVGL RKIKETVDQV EELRRDLRIK SQELEVKNAA AND KLKKMV KDQQEAEKKK VMSQEIQEQL HKQQEVIADK QMSVKEDLDK VEPAVIEAQN AVKSIKKQHL VEVRSMANPP AAVK LALES ICLLLGESTT DWKQIRSIIM RENFIPTIVN FSAEEISDAI REKMKKNYMS NPSYNYEIVN RASLACGPMV KWAIA QLNY ADMLKRVEPL RNELQKLEDD AKDNQQKANE VEQMIRDLEA SIARYKEEYA VLISEAQAIK ADLAAVEAKV NRSTAL LKS LSAERERWEK TSETFKNQMS TIAGDCLLSA AFIAYAGYFD QQMRQNLFTT WSHHLQQANI QFRTDIARTE YLSNADE RL RWQASSLPAD DLCTENAIML KRFNRYPLII DPSGQATEFI MNEYKDRKIT RTSFLDDAFR KNLESALRFG NPLLVQDV E SYDPVLNPVL NREVRRTGGR VLITLGDQDI DLSPSFVIFL STRDPTVEFP PDLCSRVTFV NFTVTRSSLQ SQCLNEVLK AERPDVDEKR SDLLKLQGEF QLRLRQLEKS LLQALNEVKG RILDDDTIIT TLENLKREAA EVTRKVEETD IVMQEVETVS QQYLPLSTA CSSIYFTMES LKQIHFLYQY SLQFFLDIYH NVLYENPNLK GVTDHTQRLS IITKDLFQVA FNRVARGMLH Q DHITFAML LARIKLKGTV GEPTYDAEFQ HFLRGNEIVL SAGSTPRIQG LTVEQAEAVV RLSCLPAFKD LIAKVQADEQ FG IWLDSSS PEQTVPYLWS EETPATPIGQ AIHRLLLIQA FRPDRLLAMA HMFVSTNLGE SFMSIMEQPL DLTHIVGTEV KPN TPVLMC SVPGYDASGH VEDLAAEQNT QITSIAIGSA EGFNQADKAI NTAVKSGRWV MLKNVHLAPG WLMQLEKKLH SLQP HACFR LFLTMEINPK VPVNLLRAGR IFVFEPPPGV KANMLRTFSS IPVSRICKSP NERARLYFLL AWFHAIIQER LRYAP LGWS KKYEFGESDL RSACDTVDTW LDDTAKGRQN ISPDKIPWSA LKTLMAQSIY GGRVDNEFDQ RLLNTFLERL FTTRSF DSE FKLACKVDGH KDIQMPDGIR REEFVQWVEL LPDTQTPSWL GLPNNAERVL LTTQGVDMIS KMLKMQMLED EDDLAYA ET EKKTRTDSTS DGRPAWMRTL HTTASNWLHL IPQTLSHLKR TVENIKDPLF RFFEREVKMG AKLLQDVRQD LADVVQVC E GKKKQTNYLR TLINELVKGI LPRSWSHYTV PAGMTVIQWV SDFSERIKQL QNISLAAASG GAKELKNIHV CLGGLFVPE AYITATRQYV AQANSWSLEE LCLEVNVTTS QGATLDACSF GVTGLKLQGA TCNNNKLSLS NAISTALPLT QLRWVKQTNT EKKASVVTL PVYLNFTRAD LIFTVDFEIA TKEDPRSFYE RGVAVLCTE UniProtKB: Cytoplasmic dynein 1 heavy chain 1 |
-Macromolecule #2: Platelet-activating factor acetylhydrolase IB subunit beta
Macromolecule | Name: Platelet-activating factor acetylhydrolase IB subunit beta type: protein_or_peptide / ID: 2 / Number of copies: 1 / Enantiomer: LEVO |
---|---|
Source (natural) | Organism: ![]() ![]() |
Molecular weight | Theoretical: 46.722918 KDa |
Recombinant expression | Organism: ![]() ![]() ![]() |
Sequence | String: GSVLSQRQRD ELNRAIADYL RSNGYEEAYS VFKKEAELDV NEELDKKYAG LLEKKWTSVI RLQKKVMELE SKLNEAKEEF TSGGPLGQK RDPKEWIPRP PEKYALSGHR SPVTRVIFHP VFSVMVSASE DATIKVWDYE TGDFERTLKG HTDSVQDISF D HSGKLLAS ...String: GSVLSQRQRD ELNRAIADYL RSNGYEEAYS VFKKEAELDV NEELDKKYAG LLEKKWTSVI RLQKKVMELE SKLNEAKEEF TSGGPLGQK RDPKEWIPRP PEKYALSGHR SPVTRVIFHP VFSVMVSASE DATIKVWDYE TGDFERTLKG HTDSVQDISF D HSGKLLAS CSADMTIKLW DFQGFECIRT MHGHDHNVSS VAIMPNGDHI VSASRDKTIK MWEVQTGYCV KTFTGHREWV RM VRPNQDG TLIASCSNDQ TVRVWVVATK ECKAELREHE HVVECISWAP ESSYSSISEA TGSETKKSGK PGPFLLSGSR DKT IKMWDV STGMCLMTLV GHDNWVRGVL FHSGGKFILS CADDKTLRVW DYKNKRCMKT LNAHEHFVTS LDFHKTAPYV VTGS VDQTV KVWECR UniProtKB: Platelet-activating factor acetylhydrolase IB subunit beta |
-Macromolecule #3: ADENOSINE-5'-DIPHOSPHATE
Macromolecule | Name: ADENOSINE-5'-DIPHOSPHATE / type: ligand / ID: 3 / Number of copies: 3 / Formula: ADP |
---|---|
Molecular weight | Theoretical: 427.201 Da |
Chemical component information | ![]() ChemComp-ADP: |
-Macromolecule #4: ADENOSINE-5'-TRIPHOSPHATE
Macromolecule | Name: ADENOSINE-5'-TRIPHOSPHATE / type: ligand / ID: 4 / Number of copies: 1 / Formula: ATP |
---|---|
Molecular weight | Theoretical: 507.181 Da |
Chemical component information | ![]() ChemComp-ATP: |
-Experimental details
-Structure determination
Method | ![]() |
---|---|
![]() | ![]() |
Aggregation state | particle |
-
Sample preparation
Buffer | pH: 7.4 |
---|---|
Vitrification | Cryogen name: ETHANE |
-
Electron microscopy
Microscope | FEI TALOS ARCTICA |
---|---|
Electron beam | Acceleration voltage: 200 kV / Electron source: ![]() |
Electron optics | Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD![]() |
Image recording | Film or detector model: GATAN K2 SUMMIT (4k x 4k) / Average electron dose: 55.0 e/Å2 |
Experimental equipment | ![]() Model: Talos Arctica / Image courtesy: FEI Company |